Congenital anomalies: Treatment options based on amniotic fluid-derived stem cells

Organogenesis

Volumn 8, Issue 3, 2012, Pages 89-95

  Kunisaki, Shaun M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Amniotic fluid; Congenital anomalies; Fetal therapy; Fetus; Mesenchymal stem cells; Stem cell therapy; Stem cells; Tissue engineering

Indexed keywords

AMNIOCENTESIS; AMNIOTIC FLUID DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; CONGENITAL DIAPHRAGM HERNIA; CONGENITAL DISORDER; CONGENITAL HEART DISEASE; FETUS ECHOGRAPHY; HUMAN; LUNG DYSPLASIA; MESENCHYMAL STEM CELL; NECROTIZING ENTEROCOLITIS; NEWBORN DISEASE; PREMATURITY; PRENATAL DIAGNOSIS; REVIEW; SPINAL DYSRAPHISM; STEM CELL TRANSPLANTATION; THORAX WALL DEFECT; TISSUE ENGINEERING; TRACHEA DISEASE;

AMNIOTIC FLUID; ANIMALS; CELLS, CULTURED; CONGENITAL ABNORMALITIES; GUIDED TISSUE REGENERATION; HUMANS; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; STEM CELLS;

ANIMALIA;

EID: 84871001931     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.22238     Document Type: Review

References (57)

1. Shaw SW, David AL, De Coppi P. Clinical applications of prenatal and postnatal therapy using stem cells retrieved from amniotic fluid. Curr Opin Obstet Gynecol 2011; 23:109-16; PMID:21386681; http://dx.doi.org/10.1097/GCO. 0b013e32834457b1
2. Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 2004; 18:877-91; PMID:15582544; http://dx.doi.org/10.1016/j. bpobgyn.2004.07.001
3. Cananzi M, Atala A, De Coppi P. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online 2009; 18(Suppl 1):17-27; PMID:19281660; http://dx.doi.org/10.1016/S1472-6483(10)60111-3
4. Kunisaki SM, Freedman DA, Fauza DO. Fetal tracheal reconstruction with cartilaginous grafts engineered from mesenchymal amniocytes. J Pediatr Surg 2006; 41:675-82, discussion 675-82; PMID:16567175; http://dx.doi.org/10.1016/j. jpedsurg.2005.12.008
5. Kaviani A, Guleserian K, Perry TE, Jennings RW, Ziegler MM, Fauza DO. Fetal tissue engineering from amniotic fluid. J Am Coll Surg 2003; 196:592-7; PMID: 12691937; http://dx.doi.org/10.1016/S1072-7515(02)01834-3
6. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C,Noort WA, Claas FH, Willemze R, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102:1548-9; PMID: 12900350; http://dx.doi.org/10.1182/blood-2003-04-1291
7. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C,de Groot-Swings GM, Claas FH, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22: 1338-45; PMID:15579651; http://dx.doi.org/10.1634/stemcells.2004-0058
8. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004; 19:1450-6; PMID:15105397; http://dx.doi.org/10.1093/humrep/deh279
9. Kunisaki SM, Armant M, Kao GS, Stevenson K, Kim H, Fauza DO. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J Pediatr Surg 2007; 42:974-9, discussion 979-80; PMID: 17560205; http://dx.doi.org/10.1016/j.jpedsurg.2007.01.031
10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7; PMID:10102814; http://dx.doi.org/10.1126/science.284.5411.143
11. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8:315-7; PMID:16923606; http://dx.doi.org/10.1080/14653240600855905
12. Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, Papadaki HA, et al. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 2007; 16:931-52; PMID:18047393; http://dx.doi.org/10.1089/scd. 2007.0036
13. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007; 40:75-90; PMID:17227297; http://dx.doi.org/10.1111/j.1365-2184. 2007.00414.x
14. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschläger M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 2003; 18:1489-93; PMID:12832377; http://dx.doi.org/10.1093/ humrep/deg279
15. Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 2009; 4:423-33; PMID: 19438317; http://dx.doi.org/10.2217/rme.09.12
16. Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL, Chang YJ. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006; 74:545-51; PMID: 16306422; http://dx.doi.org/10. 1095/biolreprod.105.046029
17. Jezierski A, Gruslin A, Tremblay R, Ly D, Smith C, Turksen K, et al. Probing stemness and neural commitment in human amniotic fluid cells. Stem Cell Rev 2010; 6:199-214; PMID:20221716; http://dx.doi.org/10.1007/s12015-010-9116-7
18. Miranda-Sayago JM, Fernández-Arcas N, Benito C, Reyes-Engel A, Carrera J, Alonso A. Lifespan of human amniotic fluid-derived multipotent mesenchymal stromal cells. Cytotherapy 2011; 13:572-81; PMID: 21208022; http://dx.doi.org/10.3109/14653249.2010.547466
19. Grisafi D, Piccoli M, Pozzobon M, Ditadi A, Zaramella P, Chiandetti L, et al. High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors. Stem Cells Dev 2008; 17:953-62; PMID: 18564037; http://dx.doi.org/10.1089/scd.2007.0188
20. Götherström C, Ringdén O, Tammik C, Zetterberg E, Westgren M, Le Blanc K. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 2004; 190:239-45; PMID:14749666; http://dx.doi.org/ 10.1016/j.ajog.2003.07.022
21. Moorefield EC, McKee EE, Solchaga L, Orlando G, Yoo JJ, Walker S, et al. Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response. PLoS One 2011; 6:e26535; PMID:22046303; http://dx.doi.org/10.1371/journal.pone.0026535
22. Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R, Six E, et al. Human and murine amniotic fluid c-Kit +Lin- cells display hematopoietic activity. Blood 2009; 113:3953-60; PMID:19221036; http://dx.doi.org/10.1182/blood-2008-10- 182105
23. Prusa AR, Marton E, Rosner M, Bettelheim D, Lubec G, Pollack A, et al. Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol 2004; 191:309-14; PMID: 15295384; http://dx.doi.org/10.1016/j.ajog.2003.12.014
24. De Coppi P, Bartsch G, Jr., Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25:100-6; PMID:17206138; http://dx.doi.org/10.1038/nbt1274
25. Arnhold S, Glüer S, Hartmann K, Raabe O, Addicks K, Wenisch S, et al. Amniotic-Fluid Stem Cells: Growth Dynamics and Differentiation Potential after a CD-117-Based Selection Procedure. Stem Cells Int 2011; 2011:715341; PMID:21437196; http://dx.doi.org/10.4061/2011/715341
26. Gekas J, Walther G, Skuk D, Bujold E, Harvey I, Bertrand OF. In vitro and in vivo study of human amniotic fluid-derived stem cell differentiation into myogenic lineage. Clin Exp Med 2010; 10:1-6; PMID: 19730985; http://dx.doi.org/10.1007/s10238-009-0060-2
27. Guan X, Delo DM, Atala A, Soker S. In vitro cardiomyogenic potential of human amniotic fluid stem cells. J Tissue Eng Regen Med 2011; 5:220-8; PMID:20687122; http://dx.doi.org/10.1002/term.308
28. Ye L, Chang JC, Lin C, Sun X, Yu J, Kan YW. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A 2009; 106:9826-30; PMID:19482945; http://dx.doi.org/10.1073/pnas.0904689106
29. Li C, Zhou J, Shi G, Ma Y, Yang Y, Gu J, et al. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet 2009; 18:4340-9; PMID:19679563; http://dx.doi.org/10.1093/hmg/ddp386
30. Galende E, Karakikes I, Edelmann L, Desnick RJ, Kerenyi T, Khoueiry G, et al. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram 2010; 12:117-25; PMID: 20677926; http://dx.doi.org/10.1089/cell.2009.0077
31. Anchan RM, Quaas P, Gerami-Naini B, Bartake H, Griffin A, Zhou Y, et al. Amniocytes can serve a dual function as a source of iPS cells and feeder layers. Hum Mol Genet 2011; 20:962-74; PMID:21156717; http://dx.doi.org/10.1093/hmg/ ddq542
32. Adzick NS, Thom EA, Spong CY, Brock JW, 3rd, Burrows PK, Johnson MP, et al. MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011; 364:993-1004; PMID:21306277; http://dx.doi.org/10.1056/NEJMoa1014379
33. Dhaulakhandi DB, Rohilla S, Rattan KN. Neural tube defects: review of experimental evidence on stem cell therapy and newer treatment options. Fetal Diagn Ther 2010; 28:72-8; PMID:20689263; http://dx.doi.org/10.1159/000318201
34. Li H, Gao F, Ma L, Jiang J, Miao J, Jiang M, et al. Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat fetuses with spina bifida aperta. J Cell Mol Med 2012; 16:1606-17; PMID:22004004; http://dx.doi.org/10.1111/j.1582-4934.2011.01470.x
35. Fauza DO, Jennings RW, Teng YD, Snyder EY. Neural stem cell delivery to the spinal cord in an ovine model of fetal surgery for spina bifida. Surgery 2008; 144:367-73; PMID:18707035; http://dx.doi.org/10.1016/j.surg.2008.05.009
36. Sartore S, Lenzi M, Angelini A, Chiavegato A, Gasparotto L, De Coppi P, et al. Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. Eur J Cardiothorac Surg 2005; 28:677-84; PMID:16188450; http://dx.doi.org/10.1016/j.ejcts.2005.07. 019
37. Yeh YC, Lee WY, Yu CL, Hwang SM, Chung MF, Hsu LW, et al. Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model. Biomaterials 2010; 31: 6444-53; PMID:20621766; http://dx.doi.org/10.1016/j.biomaterials.2010.04.069
38. Sassoli C, Pini A, Mazzanti B, Quercioli F, Nistri S, Saccardi R, et al. Mesenchymal stromal cells affect cardiomyocyte growth through juxtacrine Notch-1/Jagged-1 signaling and paracrine mechanisms: clues for cardiac regeneration. J Mol Cell Cardiol 2011; 51:399-408; PMID:21712044; http://dx.doi.org/10.1016/j.yjmcc.2011.06.004
39. Bollini S, Pozzobon M, Nobles M, Riegler J, Dong X, Piccoli M, et al. In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells. Stem Cell Rev 2011; 7:364-80; PMID:21120638; http://dx.doi.org/10.1007/s12015- 010-9200-z
40. Bollini S, Cheung KK, Riegler J, Dong X, Smart N, Ghionzoli M, et al. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev 2011; 20:1985-94; PMID:21534857; http://dx.doi.org/ 10.1089/scd.2010.0424
41. Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, et al. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010; 139:431-6, 436, e1-2; PMID: 20106404; http://dx.doi.org/ 10.1016/j.jtcvs.2009.09.057
42. Schmidt D, Achermann J, Odermatt B, Breymann C, Mol A, Genoni M, et al. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007; 116(Suppl):I64-70; PMID:17846327; http://dx.doi.org/10.1161/CIRCULATIONAHA.106. 681494
43. Weber B, Emmert MY, Behr L, Schoenauer R, Brokopp C, Drögemü ller C, et al. Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation. Biomaterials 2012; 33:4031-43; PMID: 22421386; http://dx.doi.org/10.1016/j.biomaterials.2011.11.087
44. Moss RL, Chen CM, Harrison MR. Prosthetic patch durability in congenital diaphragmatic hernia: a long-term follow-up study. J Pediatr Surg 2001; 36:152-4; PMID: 11150455; http://dx.doi.org/10.1053/jpsu.2001.20037
45. Fuchs JR, Kaviani A, Oh JT, LaVan D, Udagawa T, Jennings RW, et al. Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J Pediatr Surg 2004; 39:834-8, discussion 834-8; PMID:15185207; http://dx.doi.org/10.1016/j.jpedsurg.2004.02.014
46. Kunisaki SM, Fuchs JR, Kaviani A, Oh JT, LaVan DA, Vacanti JP, et al. Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg 2006; 41:34-9, discussion 34-9; PMID:16410104; http://dx.doi.org/10.1016/j.jpedsurg. 2005.10.011
47. Turner CG, Klein JD, Steigman SA, Armant M, Nicksa GA, Zurakowski D, et al. Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cells. J Pediatr Surg 2011; 46:57-61; PMID:21238640; http://dx.doi.org/10.1016/j.jpedsurg.2010.09.063
48. Steigman SA, Ahmed A, Shanti RM, Tuan RS, Valim C, Fauza DO. Sternal repair with bone grafts engineered from amniotic mesenchymal stem cells. J Pediatr Surg 2009; 44:1120-6, discussion 1126; PMID: 19524727; http://dx.doi.org/10.1016/j.jpedsurg.2009.02.038
49. Klein JD, Turner CG, Ahmed A, Steigman SA, Zurakowski D, Fauza DO. Chest wall repair with engineered fetal bone grafts: an efficacy analysis in an autologous leporine model. J Pediatr Surg 2010; 45: 1354-60; PMID:20620344; http://dx.doi.org/10.1016/j.jpedsurg.2010.02.116
50. Turner CG, Klein JD, Gray FL, Ahmed A, Zurakowski D, Fauza DO. Craniofacial repair with fetal bone grafts engineered from amniotic mesenchymal stem cells. J Surg Res 2012; In press; PMID:22656041; http://dx.doi.org/10.1016/ j.jss.2012.05.017
51. Kunisaki SM, Jennings RW, Fauza DO. Fetal cartilage engineering from amniotic mesenchymal progenitor cells. Stem Cells Dev 2006; 15:245-53; PMID: 16646670; http://dx.doi.org/10.1089/scd.2006.15.245
52. Jungebluth P, Alici E, Baiguera S, Le Blanc K, Blomberg P, Bozóky B, et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 2011; 378:1997-2004; PMID:22119609; http://dx.doi.org/10.1016/S0140-6736(11)61715-7
53. Zani A, Cananzi M, Eaton S, Pierro A, De Coppi P. Stem cells as a potential treatment of necrotizing enterocolitis. J Pediatr Surg 2009; 44:659-60; PMID: 19302881; http://dx.doi.org/10.1016/j.jpedsurg.2008.12.012
54. van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M, et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009; 180:1131-42; PMID:19713449; http://dx.doi.org/10.1164/rccm.200902-0179OC
55. Tropea KA, Leder E, Aslam M, Lau AN, Raiser DM, Lee JH, et al. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2012; 302:L829-37; PMID: 22328358; http://dx.doi.org/10.1152/ajplung.00347.2011
56. Klemmt PA, Vafaizadeh V, Groner B. The potential of amniotic fluid stem cells for cellular therapy and tissue engineering. Expert Opin Biol Ther 2011; 11:1297-314; PMID:21623704; http://dx.doi.org/10.1517/14712598.2011.587800
57. Liu T, Zou G, Gao Y, Zhao X, Wang H, Huang Q, et al. High Efficiency of Reprogramming CD34(+) Cells Derived from Human Amniotic Fluid into Induced Pluripotent Stem Cells with Oct4. Stem Cells Dev 2012; 21:2322-32; PMID:22264161; http://dx.doi.org/10.1089/scd.2011.0715